SweetValueLab
Write for us

Universal Health Services, Inc. — Intrinsic Value & Fair Price

UHS
NYSEHealthcareMedical - Care FacilitiesCIK 0000352915uhs.comAbout UHS
Last close · Oct 16, 2026185.10−2.26 (−1.21%)
Market cap$10.9B
Model value · DCF · Perpetuity growth · 5y
429.36
Universal Health Services closed at $185.10 — undervalued by 57% vs model.
244.92the model's range1,273.69

DCF · Perpetuity growth · 5y leads for mature & stable — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.

Other models
21.50 – 452.73
Wall St. target
189.00 2% below
Below model, 1y
20 of 20 days

Price and model value

Embed this card

UHS's close against its model value, as a 420×168 card for your own page. It updates nightly with this site and links back here.

Free to embed; keep the attribution link.
Loading chart…
What the marks mean
Daily close

Dividends

Quarterly · as of Oct 16, 2026
Yield, trailing 12 months
0.43%
Past 2 years
low 0.33%high 0.57%
Dividends per share, a year at a time
$0.80Aug ’21$0.80Aug ’22$0.80Aug ’23$0.80Sep ’24$0.80Sep ’25$0.80TTM
Dividends / free cash flow, FY2025
6.0%
Raised
—
Growth, 5 yrs
0.0% a year
Last change
—
Every payment, with ex-dates · latest $0.20, paid Sep 15, 2026

Research on UHS

No posts on UHS yet.
Studied UHS from its filings? Guest posts are reviewed before they go live.Write about UHS →

How it is valued

Valued asMature & Stable
Moderate growth (~10% recent)Moderate margins (9% net margin)Highly cyclical earningsStrong FCF yield (7.8%)
What growth the price implies: the reverse DCF

Key figures

FY2025
P/E
8.0×
EV / EBITDA
5.7×
FCF yield
7.2%
Dividend yield, TTM
0.43%
Beta
1.03
Cost of capital (WACC)
7.67%
On the lists: #9 Lowest P/E
Full financials

Analyst actions

third-party, quoted
08-03RBC Capital · target183.00
07-30Goldman Sachs · target190.00
07-29UBS · target290.00
07-08Barclays · “Equal Weight” from “Overweight”downgrade
Ratings, targets and estimates

Comparable companies

by business, not by industry label

The weekly

One email a week across every stock we cover: 13F filings, insider trades, earnings and new research. It covers the whole market, not just UHS. No account.

About Universal Health Services

Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.

CEO
Marc D. Miller
Headquarters
King of Prussia, PA
Employees
101,500
IPO
1981-07-09
Full company profile

Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; the formulas are in how we value a stock.